Newly Public Allurion Aims to Show How Med Tech Can Complement Obesity Drugs
The market is buzzing with demand for obesity pills, but Allurion Technologies is building a case that its weight loss platform—a medical device and software—is a worthy competitor to these drugs and perhaps even a companion to them. The company made debuted on the stock market debut Wednesday, raising $100 million to support commercialization of … Read more